Hassan A. Mohamed Gargoum

MD, FRCPC, FACP, FACC

Clinical Professor of Medicine, University of Saskatchewan
Specialist in Cardiology/Cardiovascular Diseases

Specialty

Adult Cardiology/Cardiovascular Diseases

Interests

  • Coronary artery disease.
  • Cardiac arrhythmia.
  • Cardiomyopathies.
  • Heart Failure.
  • Valvular Heart Disease.

Resume

Certifications/Qualifications

  • MBBS University of Garyounis, 1980
  • Diplomate in Internal Medicine; American Board of Internal Medicine, 1988
  • Diplomate in Cardiocascular Diseases; American Board of Internal Medicine, 1990
  • Royal College of Physicians and Surgeons of Canada Certification in Internal Medicine, 1990
  • Royal College of Physicians and Surgeons of Canada Certificate of Special Competency in Cardiology, 1991

Post Graduate Training

  • General Internal Medicine- McGill University, 1984- 1988.
  • General Cardiology – McGill University, 1988-1990.
  • Interventional Cardiology- McGill University, 1990- 1991.

Present Academic Rank & Position

  • Clinical Professor of Medicine, University of Saskatchewan,
  • Consultant Cardiologist, Division of Cardiology, Department of Medicine. Regina General Hospital.

Professional & Society Memberships

  • Fellow of the Royal College of Physicians & Surgeons of Canada (FRCPC).
  • Fellow of the American College of Cardiology (FACC).
  • Fellow of the American College of Physicians (FACP).
  • Member of the Canadian Medical Association (CMA).
  • Member of the Canadian Cardiovascular Society (CCS).
  • Member of the Regina Cardiac Society (RCS).
  • Member of the Saskatchewan Medical Association (SMA).
  • Member of the Ontario Medical Association (OMA).
  • Member of the Regina Health District.
  • Member of the College of Medicine, University of Saskatchewan.

Awards

  • McGill University Electrophysiology Award, 1989
  • Best Clinical Teacher Award, University of Saskatchewan, 1994.

Medical Licensure

  • College of Physicians and Surgeons of Saskatchewan (CPSS).
  • College of Physicians and Surgeons of Ontario (CPSO).

Hospital Privileges

  • Regina General Hospital (RGH)

Dr. H. Gargoum (Mohamed) does not see patients at the Pasqua hospital.

Publications

  1. Mohamed HA, Eshawish AM, Habib NA. Spontaneous Coronary Artery Dissection: Case Report and Review of the Literature, Angiology, and March 2002; 48: 111-117.
  2. Mohamed HA, Habib NA. Right ventricular intramyocardial hemorrhage due to thrombolytic therapy, presenting as cardiac tamponade. Can J Cardiol, 2003 Apr; 19(5): 581-4.
  3. Mohamed HA, Aldakar MO, and Habib NA. Acute Pulmonary Edema and Cardiogenic Shock due to Acute Hemorrhagic Necrosis of a Pheochromocytoma: a Case Report and a Review. Can J Cardiol, 2003 Apr; 19(5): 573-6.
  4. Use of Carvedilol in patients with NYHA-Class III and Class IV Congestive Heart Failure (Principle Investigator).
  5. Use of Orbifiban (a new glycoprotein inhibitor) in patients with acute coronary syndromes.(Principle investigator
  6. Mohamed, HA. Tachycardia-induced cardiomyopathy (tachycardiomyopathy). Libyan J Med,(2);AOP:061226, March 2007.
  7. Mohamed HA. Ischemic Heart Disease. Oea Textbook of Medicine. Chapter 2 and 3. First edition; 2007.
  8. Mohamed HA. Cardiomyopathy. Oea Textbook of Medicine. Chapter 4. First edition; 2007.
  9. Mohamed HA, Korkola SJ. A modern cause of an old disease: constrictive pericarditis due to percutaneous coronary intervention (PCI). A case report. Int J Angiol 2008; 17(2): 106-108.
  10. Mohamed HA. Risk stratification of patients with non-ST-segment elevation acute coronary syndrome. Libya J Med, (2); AOP:061218, March 2007.
  11. Mohamed HA. High blood pressure is good for patients with heart failure. Libyan J Med, (2); AOP:061218, March 2007.
  12. Mohamed HA. Negative Exercise stress test: Does it mean anything. Libyan J Med, (2); AOP:070103; Jun 2007.
  13. Mohamed HA. New AHA Guidelines for prevention of endocarditis. Libyan J Med, (2); AOP:070402, Sep 2007.
  14. Mohamed HA. The Courage trial: PCI versus optimal medical therapy- a point of view. Libyan J Med, (2); AOP:070402, September 2007.
  15. Mohamed HA. Rosiglitazone (Avandia) increases cardiovascular risk. Libyan J Med, (2); AOP:070402, September 2007.
  16. Mohamed HA. Syncope: Diagnosis and management. Libyan J Med, (3); AOP:080530, June 2008.
  17. Mohamed HA, Antithrombotic Therapy in Patients with Prosthetic Heart Valves. Libyan J Med, (3); AOP:090115, December 2008.

Language Spoken

  • English
  • Arabic